CHM 12.5% 1.8¢ chimeric therapeutics limited

Meet the CEO investor questions, page-20

  1. 4,153 Posts.
    lightbulb Created with Sketch. 1180
    Thanks @manlymanly, great video and some great tech Chimeric has. How long until the 3rd dose cohort readout do you think for the GBM study? Lot's to like about CHM and with only a $50m MC it's looking mighty cheap.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.